New Milford, CT, United States of America

Lee Fader



 

Average Co-Inventor Count = 10.2

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • St-Lazare, CA (2011 - 2013)
  • St. Lazare, CA (2013)
  • Laval, CA (2013 - 2014)
  • New Milford, CT (US) (2015 - 2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Lee Fader: Innovator in Hepatitis C and Cytomegalovirus Treatments

Introduction

Lee Fader is a notable inventor based in New Milford, CT (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 14 patents, Fader has focused on developing innovative compounds aimed at treating viral infections, particularly hepatitis C and cytomegalovirus.

Latest Patents

Fader's latest patents include groundbreaking work on hepatitis C inhibitor compounds. These compounds are designed to treat or prevent hepatitis C viral infection, featuring a complex formula that includes various chemical components. Additionally, he has developed inhibitors for cytomegalovirus, which are also based on intricate chemical formulas that target the disease effectively.

Career Highlights

Throughout his career, Lee Fader has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Gilead Sciences, Inc. His work has been instrumental in advancing treatments for serious viral infections, showcasing his dedication to medical innovation.

Collaborations

Fader has collaborated with several professionals in his field, including Rebekah J. Carson and Murray D. Bailey. These partnerships have contributed to the development of his patented compounds and have enhanced the impact of his research.

Conclusion

Lee Fader's innovative work in the pharmaceutical industry has led to significant advancements in the treatment of hepatitis C and cytomegalovirus. His contributions continue to influence the field and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…